Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER

We assessed the effect of once-weekly semaglutide and once-daily liraglutide on kidney outcomes in type 2 diabetes. METHODS: Pooled (n=12 637) and by-trial data from SUSTAIN 6 (Trial to Evaluate Cardiovascular and Other Long-Term Outcomes With Semaglutide in Subjects With Type 2 Diabetes; n=3297) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaman, Ahmed M., Bain, Stephen C., Bakris, George L., Buse, John B., Idorn, Thomas, Mahaffey, Kenneth W., Mann, Johannes F.E., Nauck, Michael A., Rasmussen, Søren, Rossing, Peter, Wolthers, Benjamin, Zinman, Bernard, Perkovic, Vlado
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860212/
https://www.ncbi.nlm.nih.gov/pubmed/34903039
http://dx.doi.org/10.1161/CIRCULATIONAHA.121.055459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860212/
https://www.ncbi.nlm.nih.gov/pubmed/34903039
http://dx.doi.org/10.1161/CIRCULATIONAHA.121.055459

Ejemplares similares